If you liked this article you might like

Google and Novartis Back Medicxi's New $300 Million Fund
European Stocks See New Peaks in Volatile Session
GlaxoSmithKline Shares Boosted By Renewed Push In HIV Treatment
GlaxoSmithKline Surges to New Highs